PAUL B. FERRARA is director of the Virginia Division of Forensic Science. He holds Ph.D. degrees in organic chemistry from Syracuse University and from the State University of New York. After working as a research chemist for du Pont, Dr. Ferrara entered the field of forensic science in the Northern Virginia Police Laboratory, which became the Northern Virginia Regional Facility of the statewide Forensic Laboratory System. He is a charter member and past president of the Mid-Atlantic Association of Forensic Scientists, a member of the Executive Board of the American Society of Crime Laboratory Directors (ASCLD), and chairman of the DNA Implementation Committee of ASCLD.
MICHAEL W. HUNKAPILLER is vice president for science and technology and general manager of Applied Biosystems Inc. He holds a Ph.D. in chemical engineering from the California Institute of Technology. His research focuses on the automation of procedures used in the structural analysis and synthesis of proteins and DNA. Dr. Hunkapiller is the author of more than 100 publications and the inventor on more than 20 patents. His current professional activities include service on the editorial boards of Technique, Genomics, and Analytical Biochemistry , and he is a member of the American Association for the Advancement of Science, American Chemical Society, and Human Genome Organization. Dr. Hunkapiller resigned from the committee on August 17, 1990.
HAIG H. KAZAZIAN, JR. serves as director of the Center of Medical Genetics at Johns Hopkins University School of Medicine. He is the Frank Sutland Professor of pediatric genetics and professor of medicine and gynecology and obstetrics at the medical school and professor of biology at the university. His research has concentrated on mutation analysis in genetic diseases and he has had a long interest in DNA diagnosis of genetic disease. Dr. Kazazian has served on numerous NIH committees and editorial boards. He is a member of the American Pediatric Society, American Society of Clinical Investigation, Association of American Physicians, and the American Society of Human Genetics.
MARY-CLAIRE KING is professor of epidemiology in the School of Public Health of the University of California, Berkeley and of genetics in the Department of Molecular and Cell Biology. She holds a Ph.D. in genetics from the University of California, Berkeley. Dr. King's expertise is in human genetics, genetic epidemiology, and population genetics. Her professional affiliations include membership in many NIH committees and the American Association for the Advancement of Science, American Epidemiological Society, Society for Epidemiological Research, and American Society of Human Genetics.